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ABSTRACT  
Objective: The aim of this current research was to formulate and analyze the characteristics of atenolol-β-cyclodextrin which using co-process 
crospovidone-sodium starch glycolate as the disintegrants. Evaluation which has been conducted on orally disintegrating tablets consist of wetting 
time, water absorption ratio, in vitro dispersion time, and dissolution.  
Methods: Inclusion complex of atenolol-β-cyclodextrin which were prepared using solvent evaporation method, then formulated using co-
processed crospovidone-sodium starch glycolate 1:1 (formula 1) and 1:2 (formula 2) into orally disintegrating tablets by direct compression 
technique. Orally disintegrating tablets of atenolol-β-cyclodextrin using a physical mixture of crospovidone-sodium starch glycolate 1:1 (formula 3), 
1:2 (formula 4) was also prepared as a control. The prepared formulations (F1-F4) were evaluated by several parameters such as wetting time, 
water absorption ratio, in vitro dispersion time, and dissolution. 
Results: Orally disintegrating tablets of atenolol-β-cyclodextrin using co-processed crospovidone-sodium starch glycolate 1:1 (formula 1) showed 
shorter wetting time (53.53±2.26 seconds) and in vitro dispersion time (47.44±2.49 seconds) compare to the other formulas. Formula 1 also 
exhibited the highest dissolution efficiency compare to the formula which was used in the physical mixture. The results of this study also revealed 
that there was a high correlation between in vitro dispersion time and dissolution efficiency of atenolol-β-cyclodextrin orally disintegrating tablets. 
Conclusion: Orally disintegrating tablets of atenolol-β-cyclodextrin showed enhanced dissolution efficiency due to the presence of inclusion 
complex and co-processed crospovidone-sodium starch glycolate. Formula 1 was found to be the best formula in this study. This formula effectively 
reduces in vitro dispersion time, hence the dissolution efficiency became higher. 
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Peroral drug delivery route was the most commonly used and 
convenient to deliver the drug because it is the most natural, not 
harmful, easy to use, and safe in terms of drug delivery [1]. To certain 
people, the use of conventional tablets has caused trouble, such as the 
elderly who are experiencing difficulties in using conventional dosage 
forms because of hand tremors and dysphagia [1, 2]. This condition 
produces non-compliance in a specified group of patients, especially 
geriatric. Statistics showed that approximately 50% of patients on long-
term therapy did not comply with the prescribed treatment [3]. The 
outcomes from previous work revealed that the cost of treatment, 
discomfort with treatment, and long-term therapy were common 
reasons for non-compliance [4]. To overcome these problems, an 
effective drug delivery system is needed to provide a solution to the non-
compliance issues. The orally disintegrating tablet is one of the peroral 
delivery systems which can exhibit improvement in compliance, 
especially in geriatric patients who take long-term therapy. 
Orally disintegrating tablets are solid single-unit dosage forms that 
are designed to be placed in the mouth, allowed to disperse or 
dissolve in the saliva, and then swallowed without the aid of 
additional water. Orally disintegrating tablets must disperse or 
dissolve in the mouth quickly, within seconds [5]. US FDA stated that 
orally disintegrating tablet is a tablet which disintegrates in the oral 
cavity less than 30 seconds [6]. Orally disintegrating tablets also 
provide fast disintegration of the tablets results in a quick 
dissolution of the drug and fast absorption that provide rapid onset 
of action [7, 8]. The drug may get absorbed from the pharynx and 
esophagus or from other sections of GIT as the saliva travels down. 
In such cases, bioavailability is significantly greater than that 
observed from conventional tablet dosage form [9, 10]. 
The candidate drug categories for orally disintegrating tablets are 
diverse, such as cardiovascular drugs used for chronic conditions 
with a large geriatric population as users [5]. Atenolol is classified as 
β1-blocker and widely prescribed in diverse cardiovascular diseases 
such as hypertension, angina, arrhythmias, and myocardial 
infarction [11, 12]. Atenolol is slightly soluble in water. The 
solubility of atenolol in water (25 °C) is approximately 13.3 mg/ml 
[13, 14]. Consequently, in order to increase the solubility and 
dissolution rate of atenolol, inclusion complex formation with 
cyclodextrin becomes imperative [15]. β-cyclodextrin as host 
molecules can interact with various drugs through the ability to 
entrap low solubility drugs in the hydrophobic cavity. Moreover, the 
exterior part of β-cyclodextrin which relatively hydrophilic can 
enhance the solubility of the drugs. 
Formulation of orally disintegrating tablets also can enhance the 
dissolution of atenolol, because it can produce faster disintegration 
time compare to the conventional tablets. Superdisintegrants are the 
class of compounds which primarily aid the rapid disintegration of 
orally disintegrating tablets in the oral cavity [16]. Superdisintegrants 
are strongly hygroscopic materials that aid in wicking water from the 
saliva into the internal structure of the tablets. Nevertheless, the 
hygroscopicity of superdisintegrants is such that both their 
functionality and tablet stability can be compromised by excessive 
exposure to high humidity [5]. Hence, in the orally disintegrating 
tablets formulation, there is a need to have superdisintegrants with 
low or no moisture sensitivity and rapid disintegration ability. One 
approach for improving the characteristics of superdisintegrants is co-
processing of two superdisintegrants [17]. Crospovidone and sodium 
starch glycolate were chosen for this study because of their valuable 
characteristics. Crospovidone had high capillary activity, pronounced 
hydration capacity and little tendency to produce gels. Sodium starch 
glycolate was chosen because of its high swelling capacity [5]. The aim 
of this study was to formulate and evaluate the characteristics of 
atenolol-β-cyclodextrin using co-processed crospovidone-sodium 
starch glycolates to increase water uptake, shorten the wetting time, 
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and thereby decrease the disintegration time of the tablets by 
synergism effect of these two superdisintegrants and increased the 
dissolution efficiency. 
MATERIALS AND METHODS 
Materials  
Materials that were used in this study consists of atenolol p. g 
(Refarmed Chemicals, Lugono Switzerland), β-cyclodextrin (Roquette, 
France), crospovidone (Kollidon® CL) p. g (BASF South East Asia Pre-
Ltd), sodium starch glycolate. g (Yung Zip Chemical IND. Co. LTD), 
magnesium stearate p. g (Faci Asia Pacific PTE LTD), aspartame f. g 
(Ajinomoto Co. Inc.), aqua demineralization (Laboratorium of 
qualitative chemistry, University of Surabaya), mannitol DC p. g 
(RoquetteFreses, Perancis), Aerosil® p. g (PT. Brataco), mint flavor f. g 
(KH Roberts), sodium dihydrogen phosphate. a (NaH2PO4.2H2O) p. a 
(Merck), disodium hydrogen phosphate. a (Na2HPO4.12H2O) p. a 
(Merck), sodium acetate trihydrate p. a. (Riedel), glacial acetic acid p. a 
(Merck), methanol pro-HPLC (Mallinckrodt Chemicals), Avicel PH 
102®
Inclusion complex of atenolol-β-cyclodextrin was prepared by a 
solvent evaporation method. Atenolol and β-cyclodextrin were 
dissolved separately in ethanol; then the dispersion was mixed 
thoroughly by using magnetic stirrer for 2 h, then this mixture was 
placed in a water bath (90 °C) to evaporate the solvent. The 
inclusion complexes were obtained as a crystalline powder 
pulverized. The inclusion complexes were sieved by using siever 
no.60 and stored in airtight containers till further use. 
p. g (Mingtai Chemical Co. LTD), talk (PT. Brataco), and Whatman 
filter paper no 41. 
Methods  
Preparation of inclusion complex of atenolol-β-cyclodextrin 
Preparation of co-processed superdisintegrants (crospovidone-
sodium starch glycolate) 
The co-processed superdisintegrants were prepared by the solvent 
evaporation method. A blend of crospovidone and sodium starch 
glycolate (1:1 and 1:2) was added to 50 ml of ethanol in beaker 
glass. This mixture was mixed thoroughly and stirred on a magnetic 
stirrer while maintaining the temperature between 50-60 °C until 
ethanol has been evaporated [18]. Wet granule mass was sieved 
through #40 mesh; then wet granules were dried in a hot air oven at 
60 °C for 20 min. The dried granules were sieved through #40 mesh 
and stored in airtight container and protected from light until 
further use. 
Preparation of powder mixture  
Inclusion complex of atenolol-β-cyclodextrin which have been 
prepared then mixed with several excipients to produce orally 
disintegrating tablets. Preparation of powder mixture of 
compression was performed by mixing the component in table 1. 
Inclusion complex of atenolol-β-cyclodextrin (equivalent to 25 mg of 
atenolol in each tablet) was premixed with a half portion of Aerosil 
200® for 3 min. This mixture then mixed thoroughly with co-
processed crospovidone-sodium starch glycolate, Avicel PH 102®, 
mannitol DC, aspartame, and mint flavor for 10 min in a tumbling 
mixer. In the final step, the powder mixture was mixed with talc, 
magnesium stearate, and Aerosil 200®
 
 for 3 min. 
Table 1: Formula of atenolol orally disintegrating tablet using co-processed crospovidone-sodium starch glycolate 
Contents Co-processed Physical mixture 
Formula 1 (mg) Formula 2 (mg) Formula 3 (mg) Formula 4 (mg) 
Atenolol-β-cyclodextrin 133.41 133.41 133.41 133.41 
Co-processed crospovidone-sodium starch glycolate 30 (1:1) 30 (1:2) - - 
Physical mixture crospovidone-sodium starch glycolate - - 30 (1:1) 30 (1:2) 
Avicel PH 102 94.87 ® 94.87 94.87 94.87 
Manitol DC 23.72 23.72 23.72 23.72 
Aspartam 9 9 9 9 
Mint flavor 3 3 3 3 
Magnesium stearate 1.5 1.5 1.5 1.5 
Talk 3 3 3 3 
Aerosil 200 1.5 ® 1.5 1.5 1.5 
 
Preparation of atenolol-β-cyclodextrin orally disintegrating tablets 
Orally disintegrating tablets of atenolol were prepared by direct 
compression method. The powder mixture was mixed with external 
phase, then compressed into orally disintegrating tablets using 
Erweka®
Evaluation of atenolol-β-cyclodextrin orally disintegrating tablets 
compression machine. The weight of the tablet was set at 
300 mg and 11 mm in diameter. 
Orally disintegrating tablets of atenolol-β-cyclodextrin were 
evaluated for various parameters such as wetting time, water 
absorption ratio, in vitro dispersion time, and dissolution. These 
parameters were evaluated to analyze the effect of the different 
components of superdisintegrants (co-processed crospovidone-
sodium starch glycolate (1:1 and 1:2) and physical mixture of 
crospovidone-sodium starch glycolate (1:1 and 1:2). 
Wetting time 
Wetting time is closely related to the inner structure of the tablets 
and to the hydrophilicity of the excipient. Wetting time corresponds 
to the time taken for the tablet to disintegrate when kept motionless 
on the tongue. A linear relationship exists between wetting time and 
disintegration time or in vitro dispersion time. A circular filter paper 
of 8 cm diameter is placed in a Petri dish containing 10 ml of the 
blue dye solution. A tablet is carefully placed on the surface of the 
filter paper. The time requires for developing blue color on the 
upper surface of the tablet is noted as the wetting time [19]. 
Water absorption ratio 
The weight of the tablet before keeping in the Petri dish was noted 
(Wb). Fully wetted tablet from the Petri dish was taken and 
reweighed (Wa). The water absorption ratio can be determined 
according to the following formula. 
R = Wa−Wb 
Wb
 x 100 
In vitro dispersion time  
In vitro dispersion time was measured by dropping a tablet in a 
cylinder containing 6 ml of phosphate buffer pH 6.8 (simulated 
saliva fluid) with a temperature of 37±0.5 °C. The time required for 
complete dispersion was determined [17, 18]. 
Dissolution study 
In vitro dissolution study was performed using USP Type II 
Apparatus (paddle type) at 50 rpm for 120 min. Acetate buffer pH 
4.6 was used as a dissolution medium which was maintained at 
37±0.5 °C. An aliquot (10 ml) was taken at specified time intervals 
(1, 2, 5, 15, 20, 45, and 60 min). An equal amount of fresh dissolution 
medium was replaced immediately following the withdrawal of the 
sample. The concentration of atenolol in the aliquot was determined 
using Ultra Performance Liquid Chromatography (UPLC). The data 
shown is the average of 6 determinations. A dissolution profile for 
each formula was plotted, and dissolution parameters such as %Q, 
TQ%, AUC, and dissolution efficiency was determined. 
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RESULTS AND DISCUSSION 
In this study, four formulas have been prepared to produce orally 
disintegrating tablets of atenolol-β-cyclodextrin. Two formulas 
(formula 1 and formula 2) were prepared using two different ratios 
of co-processed crospovidone-sodium starch glycolate. Formula 3 
and formula 4 were prepared as a control, using a physical mixture 
of crospovidone-sodium starch glycolate in the same ratio compare 
to the co-processed superdisintegrants. 
The powder mixture of each formula was compressed using direct 
compression technique. The compressed tablets were evaluated for 
physical properties such as organoleptic, dimension, uniformity of 
weight, wetting time, water absorption ratio, in vitro dispersion 
time, and disintegration time. These parameters were critical 
parameters to evaluate the characteristics of orally disintegrating 
tablets which were produced using different preparation method 
(co-process and physical mixture) and the different ratio (1:1 and 
1:2) of superdisintegrants. 
The organoleptic characteristics of atenolol-β-cyclodextrin orally 
disintegrating tablets which produced in this study were white, round 
shape, no odor, sweet and mint flavor. Dimension measurements of 
orally disintegrating tablets were done to ensure the dimension 
homogeneity of compressed tablets. The results showed that the 
diameter and thickness of the tablets from all formulas were uniforms. 
Uniformity of the weight test showed that all the formulas were 
uniform and met the pharmacopeia specification. The results of 
physical and chemical evaluation of atenolol-β-cyclodextrin orally 
disintegrating tablets are tabulated in table 2. 
 
Table 2: The results of physical and chemical evaluation of atenolol-β-cyclodextrin orally disintegrating tablets (formula 1, formula 2, 
formula 3, and formula 4) 
Parameters Specification Results 
Formula 1 Formula 2 Formula 3 Formula 4 
Organoleptic Shape Round Round Round Round Round 
Colour White White White White White 
Odor Mint Mint Mint Mint Mint 
Tatste Mint dan sweet Mint dan sweet Mint dan sweet Mint dan sweet Mint dan sweet 
Tablet dimension (D/T) ≤ 3.00 2.94±0.11 2.98±0.09 2.99±0.08 2,99±0,08 
In vitro dispersion (second) <60 seconds 47.44±2.49 49.67±1.86 86.68±2.43 88.83±2.14 
Wetting time (second) - 53.53±2.26 56.67±2.50 86.49±2.62 164.25±1.92 
Water absorption ratio (%) - 89.61±3.32 % 81.90±1.41 % 120.84±4.44 % 164.25±1.93 % 
AUC Dissolution  - 4343.34±179.59  4121.82±279.82 3970.94±119.60 3609.61±260.31 
Dissolution Efficiency - 72.39±2.99 % 68.70±4.66 % 66.18±1.99 % 60.16±4.34 % 
*(D/T): The ratio of the diameter and the thickness of orally disintegrating tablets. *results were expressed in mean±SD, n=6, SD-Standard Deviation 
 
Wetting time evaluation was applied to predict how fast the medium 
penetrates into the structure of orally disintegrating tablets The 
time for complete wetting was measured [20]. Six trials for each 
formula were conducted, and the standard deviation was also 
determined. The results of wetting time evaluation were shown in 
table 2. The wetting time of all the formulations was found to be in 
the range 53.53±2.26 until 146.33±3.72 seconds. The wetting times 
are the essential parameter for orally disintegrating, and those have to 
be ideally less than 1 min [21]. The wetting times of formula 1 and 
formula 2 which used co-process superdisintegrants satisfied the 
criteria of wetting times. The results of statistical analysis using One 
Way ANOVA revealed that there was a significant difference (p<0.05) 
of wetting time among all formulas. The wetting time of atenolol orally 
disintegrating tablets which used co-process crospovidone-sodium 
starch glycolate was shorter than atenolol orally disintegrating tablets 
which used the physical mixture of these superdisintegrants. Hence, 
there was no significant difference in wetting time between orally 
disintegrating tablets of atenolol which used co-processed 
crospovidone-sodium starch glycolate in 1:1 ratio and 1:2 ratios. One 
of the most desirable properties of the disintegrants is rapid swelling 
without gel formation since high viscosity on the surface of the tablet 
will prevent water penetration into the tablet matrix [5]. It was 
observed that co-processed superdisintegrants produce the inner 
structure of an orally disintegrating tablet more porous so that the 
wetting time became shorter.  
Orally disintegrating tablets of atenolol which used co-process 
crospovidone-sodium starch glycolate exhibited shorter wetting 
time and needed less water to disintegrate. It was observed from the 
results of the water absorption ratio test. Water absorption ratio is 
an important criterion for understanding the capacity of 
disintegrants to swell in the presence of a little amount of water 
[21]. Orally disintegrating tablets of atenolol-β-cyclodextrin which 
used co-process crospovidone-sodium starch glycolate 1:1 showed 
the lowest water absorption ratio (p<0.05) compare to the other 
formulas. The difference in water absorption ratio among the four 
formulas in this study was due to the water uptake and the swelling 
behavior of superdisintegrants [22]. The difference of super-
disintegrants preparation (co-processed and physical mixture) also 
influence the water absorption ratios of atenolol-β-cyclodextrin 
orally disintegrating tablets. Co-processed super-disintegrants 
reduce the water absorption ratio of orally disintegrating tablets, 
therefore the wetting time of the tablets became shorter. It can be 
concluded co-process superdisintegrants produce the higher ability 
of superdisintegrants to wick the water inside their structure and 
became more hydrated. This phenomenon can occur because co-
process crospovidone-sodium starch glycolate combined the 
capillary characteristics of crospovidone and swelling effect of 
sodium starch glycolate in tablets disintegration mechanism. Co-
processed superdisintegrants promote shorter wetting time of the 
tablets without high water absorption inside the structure of the 
tablets. The small amount of water or moisture which penetrated 
inside the structure of the tablets will produce enough pressure to 
disintegrate atenolol-beta-cylodextrin orally disintegrating tablets. 
Based on this facts, co-processed superdisintegrants were promising 
to attempt the physical stability problems of orally disintegrating 
tablets which are formulated using a high amount of 
superdisintegrants. However, the increasing of sodium starch 
glycolate portion in co-processed crospovidone-sodium starch 
glycolate 1:2 showed a significant escalation in water absorption 
ratio. This was due to the characteristics of sodium starch glycolate 
which absorbed water until 200%-300% [5, 23].  
In vitro dispersion time is a special parameter in which the time 
needed by the tablets to produce complete dispersion is measured 
[24]. In vitro dispersion time describe the behavior of orally 
disintegrating tablets when contact with a small amount of saliva in 
the mouth cavity [25]. The internal structure of the tablets, water 
absorption mechanism, and swelling characteristic of 
superdisintegrants are suggested to be the mechanisms of 
disintegration [26]. The results of in vitro dispersion time indicated 
that orally disintegrating tablets of atenolol-β-cyclodextrin which 
using co-process crospovidone-sodium starch glycolate dispersed 
rapidly in the mouth less than 60 seconds. Meanwhile, disintegrating 
tablets of atenolol-β-cyclodextrin which using a physical mixture of 
crospovidone-sodium starch glycolate dispersed in the mouth 
longer. The results of statistical analysis using One Way ANOVA 
revealed that there was a significant difference (p<0.05) between 
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orally disintegrating tablets of atenolol-β-cyclodextrin which using 
co-process crospovidone-sodium starch glycolate and physical 
mixture of this superdisintegrants. Such a difference in 
disintegration time between both preparations of super-
disintegrants indicates which there might be an improvement of 
capillary action on co-process superdisintegrants. This condition 
which might have led to improving water uptake [18]. It was also 
observed that formula 1 which using co-process crospovidone-
sodium starch glycolate 1:1 took the shortest time to disperse in the 
small amount of buffer phosphate pH 6.8 (±6 ml). There was a 
correlation between wetting time and in vitro dispersion time. The 
faster water can penetrate the structure of the tablets; the faster the 
tablets will be dispersed in the medium [25]. It was revealed that 
formula 1 which using co-process crospovidone-sodium starch 
glycolate 1:1 produce better wetting time, water absorption ratio, 
and in vitro dispersion time compare to the other formulas.  
Dissolution study of atenolol orally disintegrating tablets was 
performed in pH 4.6 acetate buffer using USP Dissolution test 
apparatus with a paddle stirrer. Profile dissolutions of atenolol 
orally disintegrating tablet formula 1, formula 2, formula 3, and, 
formula 4 are shown in fig. 1. 
  
 
Fig. 1: Dissolution profile of orally disintegrating tablets of atenolol-β-cyclodextrin formula 1, formula 2, formula 3, and formula 4 
[mean±SD, n=6] 
 
The result showed that formula 1 which using co-process 
crospovidone-sodium starch glycolate 1:1 release the highest 
amount of atenolol in 60 min among all formulas. Statistical analysis 
of area under the dissolution curve (AUC) using one-way ANOVA 
represented that there was a significant difference (p<0,05) between 
formulas which using co-process and physical mixture 
crospovidone-sodium starch glycolate. The results also revealed that 
formula 1 had shown the highest dissolution efficiency and the most 
rapid drug dissolution among all formulas. The rapid drug 
dissolution may be due to the presence of co-process 
superdisintegrants, which swells due to the rapid uptake of water 
from medium resulting in the breakdown of the tablet into smaller 
particles with the increased surface area, and hence increase the 
release of the drug into the dissolution medium [27, 28].  
From this present work, it concludes that co-process crospovidone-
sodium starch glycolate implied positive impact on wetting time, 
water absorption ratio, dispersion time, and dissolution efficiency of 
atenolol-β-cyclodextrin orally disintegrating tablets. The results of 
evaluation parameters suggested that co-processed crospovidone-
sodium starch glycolate in the 1:1 ratio was the best composition to 
produce efficacious orally disintegrating tablets of atenolol-β-
cyclodextrin as compared to the physical mixture.  
CONCLUSION 
Based on the results of this study, it can be concluded that co-
process superdisintegrants crospovidone-sodium starch glycolate 
could lead to the formation of rapid disintegrating and higher 
dissolution efficiency of atenolol-β-cyclodextrin compared to the 
physical mixture. Among four formulas which have been analyzed in 
this study, formula 1 (co-process crospovidone-sodium starch 
glycolate 1:1) is the best formulation because this formula dispersed 
in the least time and released the highest percentage of atenolol in 
the same time. The results also revealed that the difference of 
superdisintegrants preparation (co-process and physical mixture) 
and the amount of crospovidone and sodium starch glycolate which 
has been used in the formulas (1:1 and 1:2) significantly affect the 
dependent variables such as wetting time, water absorption ratio, in 
vitro dispersion time, and dissolution.  
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